Jazz Pharmaceuticals, Inc. (NASDAQ: JAZZ) reported Q1 EPS of $0.91, $0.07 better than the analyst estimate of $0.84.

For earnings history and earnings-related data on Jazz Pharmaceuticals, Inc. (JAZZ) click here.

Earnings